Caption Management, LLC Corbus Pharmaceuticals Holdings, Inc. Call Options Transaction History

Caption Management, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2020 Feb 16, 2021	SELL	$0.94 - $1.89 $116,184 - $233,604	-123,600 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$1.5 - $9.38 $533,850 - $3.34 Million	-355,900 Reduced 74.22%	123,600 $224,000
Q2 2020 Aug 14, 2020	BUY	$4.79 - $8.39 $1.91 Million - $3.35 Million	399,500 Added 499.38%	479,500 $4.02 Million
Q1 2020 May 15, 2020	BUY	$3.44 - $7.21 $275,200 - $576,800	80,000 New	80,000 $420,000

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $2.08B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.